AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|
25 C
New York
Saturday, August 1, 2026

Tag: release

Native Hydrate Variety Pack Delivers Sugar-Free Hydration with Full Electrolyte Profile and Nine Essential Amino Acids

Clean-label hydration meets real-world functionality in NativePath’s new stick pack assortment featuring natural flavors, third-party tested ingredients, and a complete hydration matrix designed for daily wellness.
Clean-label hydration meets real-world functionality in NativePath’s new stick pack assortment featuring natural flavors, third-party tested ingredients, and a complete hydration matrix designed for daily wellness.

Native Creatine Responds to 2025 Surge in Creatine Interest Among Women Over 50 Seeking Non-Gym Solutions

NativePath’s Clean-Label Creatine Powder Combines L-Leucine, L-Carnitine, and Creatine Monohydrate for Daily Muscle and Energy Support Without Resistance Training
NativePath’s Clean-Label Creatine Powder Combines L-Leucine, L-Carnitine, and Creatine Monohydrate for Daily Muscle and Energy Support Without Resistance Training

New Fat Burner for Women Launched Over the Counter – PhenQ Medically Accredited Fat Burning Supplement

Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide.
Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide.

Kaleo AI Launches Revolutionary Real-Time Translation Platform for Churches, Breaking Language Barriers in 150+ Languages

Toronto, Canada, July 08, 2025 (GLOBE NEWSWIRE) -- Kaleo AI announced the official launch of its groundbreaking real-time translation platform designed specifically for churches, enabling congregations to instantly translate their services into more than 150 languages and dialects. With this solution, churches can finally reach diverse communities with the gospel, removing language as a barrier to worship and discipleship.

Crédit Agricole d’Ile-de-France : Communiqué de mise à disposition du prospectus relatif aux parts sociales 2025

PRINCIPALES CARACTÉRISTIQUES DE L'ÉMISSION DE PARTS SOCIALES
PAR LES CAISSES LOCALES AFFILIÉES À LA CAISSE RÉGIONALE
DE CRÉDIT AGRICOLE MUTUEL DE PARIS ET D’ILE DE FRANCE

Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare

Transforming Healthcare Ltd Unveils the Healthcare Convergence Framework® AI/Robotics Self-Assessment Scorecard
Transforming Healthcare Ltd Unveils the Healthcare Convergence Framework® AI/Robotics Self-Assessment Scorecard

The Dawn Project Urges Legislators To Ban Tesla Full Self-Driving Over Critical Safety Defects Published in New Report to Congress

SANTA BARBARA, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Public safety advocacy group The Dawn Project has called on legislators to take action to ban Tesla’s Full Self-Driving software from public roads over the litany of critical safety defects uncovered by the group’s safety tests of the software.

Entrée en négociations exclusives en vue d’un projet de cession de M LEGO à un groupe industriel de premier plan

Entrée en négociations exclusives en vue d’un projet de cession de M LEGO à un groupe industriel de premier plan

ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds

WESTON, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, today announced its entry into a warrant inducement agreement with a single institutional investor of the Company. Terms of the warrant inducement agreement include the immediate exercise of Series A-2 Warrants to purchase up to 957,200 shares of common stock (the “Series A-2 Warrants”) and Series A-3 Warrants to purchase up to 2,105,265 shares of common stock (the “Series A-3 Warrants,” and together with the Series A-2 Warrants, the “Existing Warrants”) at a reduced exercise price of $0.67. Gross cash proceeds were approximately $2.0 million before deducting financial advisor fees and other transaction expenses. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes.

On July 12, LA Galaxy’s Home Stadium Will Be Taken Over by Nongshim!

Nongshim Night on July 12 brings free sampling, giveaways, and fan activities to LA Galaxy’s home match as part of Nongshim’s official sponsorship.

LECTRA: Monthly declaration of the total number of shares and voting rights composing the company’s capital (at June 30th, 2025)

Monthly declaration of the total number of shares and voting rights composing the company's capital (at June 30th, 2025)

FLUENT Celebrates First Adult-Use Dispensary with the rebrand of the recently acquired Kingston Dispensary in New York

The rebrand marks a major milestone following RIV Capital acquisition, signaling FLUENT’s enthusiastic push into the Empire State’s adult-use market
The rebrand marks a major milestone following RIV Capital acquisition, signaling FLUENT’s enthusiastic push into the Empire State’s adult-use market

From Stem Cells to CAR-T: LivMedCell Expands Its Role in the Future of Medicine

LivMedCell is Turkey’s first hospital-based stem cell production center operating under GMP standards, located within Liv Hospital in Istanbul.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelease